Nomination Committee of Surgical Science Sweden AB (publ)

SUSPressemeddelelse01.10.2026, 09.30

The following members have been appointed to Surgical Sciences' Nomination Committee for the 2027 Annual General Meeting:

Åsa Hedin, appointed by Marknadspotential AB
Roland Bengtsson, appointed by Semelin Kapitalförvaltning AB
Anna Sundberg, appointed by Handelsbanken Fonder

The Chairman of the Board, Gisli Hennermark, shall be co-opted to the Nomination Committee except when the Nomination Committee considers the matter of the Chairman of the Board.

The appointments have been made in accordance with the instructions regarding principles for the appointment of the company’s Nomination Committee established at the Annual General Meeting of Surgical Science on May 16, 2024. The shareholders that have appointed the members of the Nomination Committee represented in aggregate just above 35 percent of all shares in the company as of August 31, 2026.

The Nomination Committee shall prepare and submit proposals to the Annual General Meeting regarding: (i) election of Chairman of the Meeting, (ii) election of board members, (iii) election of Chairman of the Board, (iv) resolution on board remuneration with the division between the chairman and other members of the board, (v) resolution on remuneration for the members of the Remuneration and Audit Committee (if applicable), (vi) election of auditors, (vii) resolution on remuneration of auditors, and (viii) to the extent deemed necessary, resolution on amendments in current rules for the Nomination Committee.

The Annual General Meeting of Surgical Science Sweden AB (publ) will be held on Wednesday, May 19, 2027 in Gothenburg. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so in due time before the 2027 Annual General Meeting so that the Nomination Committee has time to consider the proposal. Proposals may be sent to Surgical Science Sweden AB (publ), Att: Nomination Committee, Drakegatan 7A, 412 50 Gothenburg, Sweden.

Gothenburg, Sweden, October 1, 2026
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

About Surgical Science Sweden AB (publ)

Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge.

Surgical Science has approximately 320 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Cleveland, US; Cardiff, UK; and Hong Kong and Shenzhen, China. Through sales offices in these markets and a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB.